Antengene
- Biotech or pharma, therapeutic R&D
Antengene is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for cancer patients.
We are currently seeking global partnership for our differentiating cancer and autoimmune programs as well as AnTenGager, the second generation T cell platform (2+1 structure with masking technology) we developed.
For AnTenGager TCE platform, we are open to partnership opportunities at the program and platform level to develop novel T-cell engagers (TCEs) for autoimmune diseases etc. For platform collaborations, we welcome partners to bring their own DAA/antibody to integrate into AnTenGager™, or to just nominate targets for us to do (early) development of bi- or trispecific TCE programs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}